Craig Coleman
Professor/Pharmacy Practice
Storrs Mansfield
Are you Craig Coleman?
How to update your information.
Scholarly Contributions
620 Scholarly Contributions
Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation.
2012
Research Type: Journal Article
Effect of practitioner education on adherence to asthma treatment guidelines.
2003
Research Type: Journal Article
Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.
2007
Research Type: Journal Article
Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis.
2005
Research Type: Journal Article
Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis.
2010
Research Type: Journal Article
Effect of topiramate on weight gain in patients receiving atypical antipsychotic agents
2013
Research Type: Journal Article
Effect of vital sign measurement timing on Pulmonary Embolism Severity Index (PESI) and simplified PESI 30-day mortality risk determination.
2016
Research Type: Other Scholarly Work
Effectiveness and Safety of Antiepileptic Medications in Patients with Epilepsy.
2012
Research Type: Journal Article
Effectiveness and Safety of Apixaban and Rivaroxaban Versus Warfarin for the Secondary Prevention of Stroke or Systemic Embolism Among Nonvalvular Atrial Fibrillation Patients
2017
Research Type: Poster/Presentation
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation.
2018
Research Type: Journal Article
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
2017
Research Type: Journal Article
Effectiveness and Safety of Outpatient Rivaroxaban versus Warfarin in Patients with Provoked Acute Venous Thromboembolism
2018
Research Type: Poster/Presentation
Effectiveness and Safety of Rivaroxaban Compared to Low Molecular-Weight Heparin in Patients with Cancer-Associated Venous Thromboembolism: A Real-World Analysis.
2020
Research Type: Poster/Presentation
Effectiveness and Safety of Rivaroxaban Versus Warfarin among Nonvalvular Atrial Fibrillation Patients with Concomitant Obstructive Sleep Apnea.
2023
Research Type: Journal Article
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism.
2018
Research Type: Journal Article
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Obese Nonvalvular Atrial Fibrillation Patients: Analysis of Electronic Health Record Data.
2020
Research Type: Journal Article
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients 80+ Years-of-Age with Nonvalvular Atrial Fibrillation.
2017
Research Type: Journal Article
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients with Nonvalvular Atrial Fibrillation and Heart Failure
2018
Research Type: Poster/Presentation
Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis.
2018
Research Type: Journal Article